$ZVRA
ZEVRA THERAPEUTICS, INC.

2024 Q4 Form 10-Q Financial Statement

#000143774924034916 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.695M
YoY Change 27.63%
Cost Of Revenue $3.848M
YoY Change 2572.22%
Gross Profit -$153.0K
YoY Change -105.56%
Gross Profit Margin -4.14%
Selling, General & Admin $16.21M
YoY Change 178.58%
% of Gross Profit
Research & Development $10.95M
YoY Change -10.99%
% of Gross Profit
Depreciation & Amortization $1.617M
YoY Change 2595.0%
% of Gross Profit
Operating Expenses $27.15M
YoY Change 49.89%
Operating Profit -$27.31M
YoY Change 77.73%
Interest Expense -$1.173M
YoY Change -420.49%
% of Operating Profit
Other Income/Expense, Net -$5.919M
YoY Change -495.66%
Pretax Income -$33.23M
YoY Change 139.58%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$33.23M
YoY Change 136.56%
Net Earnings / Revenue -899.19%
Basic Earnings Per Share -$0.69
Diluted Earnings Per Share -$0.70
COMMON SHARES
Basic Shares Outstanding 53.38M 52.62M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $89.38M
YoY Change 7.76%
Cash & Equivalents $54.04M
Short-Term Investments $35.34M
Other Short-Term Assets $2.276M
YoY Change -94.79%
Inventory
Prepaid Expenses
Receivables $7.790M
Other Receivables $0.00
Total Short-Term Assets $99.44M
YoY Change -27.42%
LONG-TERM ASSETS
Property, Plant & Equipment $607.0K
YoY Change -5.45%
Goodwill $4.700M
YoY Change
Intangibles $70.61M
YoY Change
Long-Term Investments $6.105M
YoY Change
Other Assets $512.0K
YoY Change 245.95%
Total Long-Term Assets $92.11M
YoY Change 4577.96%
TOTAL ASSETS
Total Short-Term Assets $99.44M
Total Long-Term Assets $92.11M
Total Assets $191.6M
YoY Change 37.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $24.46M
YoY Change 86.75%
Accrued Expenses $540.0K
YoY Change 35.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $34.48M
YoY Change 58.8%
LONG-TERM LIABILITIES
Long-Term Debt $58.90M
YoY Change 51.81%
Other Long-Term Liabilities $5.521M
YoY Change 1214.52%
Total Long-Term Liabilities $64.43M
YoY Change 15239.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $34.48M
Total Long-Term Liabilities $64.43M
Total Liabilities $121.8M
YoY Change 70.29%
SHAREHOLDERS EQUITY
Retained Earnings -$469.6M
YoY Change 38.33%
Common Stock $550.4M
YoY Change 31.63%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.98M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $69.77M
YoY Change
Total Liabilities & Shareholders Equity $191.6M
YoY Change 37.82%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$33.23M
YoY Change 136.56%
Depreciation, Depletion And Amortization $1.617M
YoY Change 2595.0%
Cash From Operating Activities -$18.14M
YoY Change 291.81%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities -$31.35M
YoY Change -29.19%
Cash From Investing Activities -$31.35M
YoY Change -29.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 64.77M
YoY Change 146.63%
NET CHANGE
Cash From Operating Activities -18.14M
Cash From Investing Activities -31.35M
Cash From Financing Activities 64.77M
Net Change In Cash 15.27M
YoY Change -166.89%
FREE CASH FLOW
Cash From Operating Activities -$18.14M
Capital Expenditures $0.00
Free Cash Flow -$18.14M
YoY Change 277.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Registrant Name
EntityRegistrantName
ZEVRA THERAPEUTICS, INC.
dei Entity Central Index Key
EntityCentralIndexKey
0001434647
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54803056
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53227364
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43110360
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41534668
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1545000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4619000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2023Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2023Q4 us-gaap Goodwill
Goodwill
4700000 usd
CY2023Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2000000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
6500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
6500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
6500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
6500000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
6500000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-36913
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-5894398
dei Entity Address Address Line1
EntityAddressAddressLine1
1180 Celebration Boulevard, Suite 103
dei Entity Address City Or Town
EntityAddressCityOrTown
Celebration
dei Entity Address State Or Province
EntityAddressStateOrProvince
FL
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
34747
dei City Area Code
CityAreaCode
321
dei Local Phone Number
LocalPhoneNumber
939-3416
dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value per share
dei Trading Symbol
TradingSymbol
ZVRA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
53375932
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54039000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
43049000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
35337000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
24688000 usd
CY2024Q3 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
7790000 usd
CY2023Q4 us-gaap Accounts And Other Receivables Net Current
AccountsAndOtherReceivablesNetCurrent
17377000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2276000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1824000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
99442000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
86938000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
8756000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9841000 usd
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
6105000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
0 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
607000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
736000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
820000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
790000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
4701000 usd
CY2023Q4 us-gaap Goodwill
Goodwill
4701000 usd
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
70608000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
69227000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
512000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
94000 usd
CY2024Q3 us-gaap Assets
Assets
191551000 usd
CY2023Q4 us-gaap Assets
Assets
172327000 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
24464000 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
28403000 usd
CY2024Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
37700000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
540000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
543000 usd
CY2024Q3 zvra Discount And Rebate Liabilities Current
DiscountAndRebateLiabilitiesCurrent
8547000 usd
CY2023Q4 zvra Discount And Rebate Liabilities Current
DiscountAndRebateLiabilitiesCurrent
4550000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
930000 usd
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
2524000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
34481000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
73720000 usd
CY2024Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
58904000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
5066000 usd
CY2024Q3 zvra Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
13902000 usd
CY2023Q4 zvra Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
16100000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
483000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
456000 usd
CY2024Q3 zvra Discount And Rebate Liabilities Noncurrent
DiscountAndRebateLiabilitiesNoncurrent
8490000 usd
CY2023Q4 zvra Discount And Rebate Liabilities Noncurrent
DiscountAndRebateLiabilitiesNoncurrent
7663000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
5521000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
7458000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
121781000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
110463000 usd
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
5000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
4000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
550413000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
472664000 usd
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
10983000 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10983000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-469550000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-399778000 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-115000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-43000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
69770000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
61864000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
191551000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
172327000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3695000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
2895000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
11569000 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
14541000 usd
CY2024Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
2303000 usd
CY2023Q3 us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
144000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
6051000 usd
us-gaap Cost Of Goods And Service Excluding Depreciation Depletion And Amortization
CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
946000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
1545000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
0 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
4619000 usd
us-gaap Cost Of Goods And Services Sold Amortization
CostOfGoodsAndServicesSoldAmortization
0 usd
CY2024Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
10945000 usd
CY2023Q3 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
12297000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
33743000 usd
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
28385000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
16208000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5818000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
38743000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
19657000 usd
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
27153000 usd
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
18115000 usd
us-gaap Costs And Expenses
CostsAndExpenses
72486000 usd
us-gaap Costs And Expenses
CostsAndExpenses
48042000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-27306000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-15364000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-71587000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-34447000 usd
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
2312000 usd
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
366000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5157000 usd
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
745000 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
4746000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-3678000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4660000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4253000 usd
CY2024Q3 zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-90000 usd
CY2023Q3 zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-124000 usd
zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-64000 usd
zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-451000 usd
CY2024Q3 zvra Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
1049000 usd
CY2023Q3 zvra Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
1738000 usd
zvra Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
2248000 usd
zvra Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
4331000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5919000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5174000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1815000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8290000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-33225000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10190000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-69772000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-26157000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
177000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-0 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-33225000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10367000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69772000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26157000 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47808817
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34724614
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43843851
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34364075
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-33225000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-10367000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-69772000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-26157000 usd
CY2024Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-536000 usd
CY2023Q3 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
5000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-72000 usd
us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-333000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-536000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-72000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-333000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-33761000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10362000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-69844000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26490000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-16622000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2119000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
56000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
71000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1146000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
184000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
48818000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-19925000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2632000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
193000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
480000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
280000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
32478000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-33225000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6137000 usd
CY2024Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
64517000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
150000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
92000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
157000 usd
CY2024Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-536000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
69770000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-13217000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
945000 usd
CY2023Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3447000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
42000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-176000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
59267000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-2573000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2151000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
165000 usd
CY2023Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-162000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
58873000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10367000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1440000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
11500000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
71000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
5000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
61522000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69772000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26157000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
10888000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
4482000 usd
us-gaap Inventory Write Down
InventoryWriteDown
5244000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
1489000 usd
us-gaap Paid In Kind Interest
PaidInKindInterest
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4741000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
219000 usd
zvra Fair Value Adjustment Of Warrants And Cvr Liability
FairValueAdjustmentOfWarrantsAndCvrLiability
-4660000 usd
zvra Fair Value Adjustment Of Warrants And Cvr Liability
FairValueAdjustmentOfWarrantsAndCvrLiability
-4159000 usd
zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-64000 usd
zvra Fair Value Adjustment Of Investments
FairValueAdjustmentOfInvestments
-451000 usd
zvra Loss On Sublease And Disposal Of Property And Equipment
LossOnSubleaseAndDisposalOfPropertyAndEquipment
0 usd
zvra Loss On Sublease And Disposal Of Property And Equipment
LossOnSubleaseAndDisposalOfPropertyAndEquipment
157000 usd
zvra Consulting Fees Paid In Stock
ConsultingFeesPaidInStock
399000 usd
zvra Consulting Fees Paid In Stock
ConsultingFeesPaidInStock
138000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-147000 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
30000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
-9587000 usd
us-gaap Increase Decrease In Accounts And Other Receivables
IncreaseDecreaseInAccountsAndOtherReceivables
1628000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
452000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-27000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4159000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-190000 usd
zvra Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-389000 usd
zvra Increase Decrease In Operating Lease Rightofuse Asset
IncreaseDecreaseInOperatingLeaseRightofuseAsset
-243000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-0 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
93000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-10590000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
5400000 usd
zvra Increase Decrease In Discount And Rebate Liabilities
IncreaseDecreaseInDiscountAndRebateLiabilities
4824000 usd
zvra Increase Decrease In Discount And Rebate Liabilities
IncreaseDecreaseInDiscountAndRebateLiabilities
3895000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-395000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-326000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1031000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
716000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-53415000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-17377000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
-0 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
224000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
41488000 usd
us-gaap Payments To Acquire Other Investments
PaymentsToAcquireOtherInvestments
45821000 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
-0 usd
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
25426000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
24798000 usd
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
43496000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-16690000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-27975000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
58990000 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
38801000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
2091000 usd
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
-0 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
42700000 usd
us-gaap Repayments Of Debt
RepaymentsOfDebt
12800000 usd
zvra Proceeds From Insurance Financing Arrangements
ProceedsFromInsuranceFinancingArrangements
1082000 usd
zvra Proceeds From Insurance Financing Arrangements
ProceedsFromInsuranceFinancingArrangements
1256000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
643000 usd
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
219000 usd
zvra Payments Of Principal On Insurance Financing Arrangements
PaymentsOfPrincipalOnInsuranceFinancingArrangements
431000 usd
zvra Payments Of Principal On Insurance Financing Arrangements
PaymentsOfPrincipalOnInsuranceFinancingArrangements
564000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3447000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
65819000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
-0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
81312000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23460000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-217000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-305000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
10990000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22197000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43049000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
65466000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
54039000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
43269000 usd
us-gaap Interest Paid Net
InterestPaidNet
3668000 usd
us-gaap Interest Paid Net
InterestPaidNet
456000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69800000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26200000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-469600000 usd
CY2024Q1 zvra Common Stock Registered Shares
CommonStockRegisteredShares
2269721
CY2024Q2 zvra Common Stock Registered Maximum Offering Price
CommonStockRegisteredMaximumOfferingPrice
350000000 usd
CY2021Q4 srt Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"><i><b>Use of Estimates</b></i></p> <p style="margin: 0pt; text-align: justify; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On an ongoing basis, the Company evaluates its estimates and assumptions, including those related to revenue recognition, the useful lives of property and equipment, the recoverability of long-lived assets, the incremental borrowing rate for leases, and assumptions used for purposes of determining stock-based compensation, income taxes, the fair value of investments and the fair value of the warrant liabilities, contingent value right ("CVR") liabilities and discount and rebate liabilities, among others. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable, the results of which form the basis for making judgments about the carrying value of assets and liabilities.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"> </p>
CY2024Q3 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
41400000 usd
CY2023Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
24700000 usd
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
100000 usd
CY2023 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
600000 usd
CY2024Q3 us-gaap Inventory Write Down
InventoryWriteDown
2000000 usd
us-gaap Inventory Write Down
InventoryWriteDown
5200000 usd
CY2023Q3 us-gaap Inventory Write Down
InventoryWriteDown
0 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
4549000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
2938000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
3084000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1884000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
1123000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
5019000 usd
CY2024Q3 us-gaap Inventory Noncurrent
InventoryNoncurrent
8756000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
9841000 usd
CY2024Q3 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
959000 usd
CY2023Q4 us-gaap Debt Instrument Unamortized Discount Premium Net
DebtInstrumentUnamortizedDiscountPremiumNet
-148000 usd
CY2024Q3 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1172000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
82000 usd
CY2024Q3 us-gaap Notes Payable
NotesPayable
58904000 usd
CY2023Q4 us-gaap Notes Payable
NotesPayable
5066000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2024Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
0 usd
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54803056
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43110360
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53227364
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41534668
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
20250369
CY2023Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
16695928
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41534668
CY2024Q1 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
9000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
306826
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41850494
CY2024Q2 us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
97747
CY2024Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
41820
CY2024Q2 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1403
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41991464
CY2024Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
32820
CY2024Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
10615385
CY2024Q3 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
39750
CY2024Q3 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
547945
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
53227364
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5483537
CY2023Q4 us-gaap Stock Issued During Period Shares Acquisitions
StockIssuedDuringPeriodSharesAcquisitions
1382489
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 zvra Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
13900000 usd
CY2023Q4 zvra Derivative And Warrant Liability Noncurrent
DerivativeAndWarrantLiabilityNoncurrent
16100000 usd
CY2024Q3 zvra Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
6000000 usd
zvra Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
2200000 usd
CY2023Q3 zvra Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
3700000 usd
zvra Fair Value Adjustment Of Put Option Net Of Tax
FairValueAdjustmentOfPutOptionNetOfTax
4300000 usd
CY2021Q2 zvra Employee Stock Purchase Plan Maximum Number Of Issuable Shares
EmployeeStockPurchasePlanMaximumNumberOfIssuableShares
1500000
us-gaap Stock Issued During Period Shares Employee Stock Purchase Plans
StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
257575
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
6137000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1387000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10888000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3081000 usd
zvra Class Of Warrant Or Right Liability Weighted Average Fair Value
ClassOfWarrantOrRightLiabilityWeightedAverageFairValue
2.54
CY2023 zvra Class Of Warrant Or Right Liability Weighted Average Fair Value
ClassOfWarrantOrRightLiabilityWeightedAverageFairValue
2.94
CY2023Q4 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
16100000 usd
zvra Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Cumulative Effect Adjustment
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityCumulativeEffectAdjustment
-2198000 usd
CY2024Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
13902000 usd
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14471534
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11514529
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
14471534
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11514529
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-33225000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-10367000 usd
us-gaap Net Income Loss
NetIncomeLoss
-69772000 usd
us-gaap Net Income Loss
NetIncomeLoss
-26157000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
47809000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34725000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43844000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34364000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.69
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.59
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.76
zvra Lessee Lease Option To Extend Maximum Term
LesseeLeaseOptionToExtendMaximumTerm
P5Y
zvra Lessee Lease Option To Terminate Term
LesseeLeaseOptionToTerminateTerm
P1Y
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
12000 usd
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
26000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
36000 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
90000 usd
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
0 usd
CY2024Q3 zvra Finance Lease Cost Total
FinanceLeaseCostTotal
12000 usd
CY2023Q3 zvra Finance Lease Cost Total
FinanceLeaseCostTotal
26000 usd
zvra Finance Lease Cost Total
FinanceLeaseCostTotal
36000 usd
zvra Finance Lease Cost Total
FinanceLeaseCostTotal
90000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
119000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
113000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
330000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
340000 usd
CY2024Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
59000 usd
CY2023Q3 us-gaap Short Term Lease Cost
ShortTermLeaseCost
55000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
177000 usd
us-gaap Short Term Lease Cost
ShortTermLeaseCost
165000 usd
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
26000 usd
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
13000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
39000 usd
us-gaap Variable Lease Cost
VariableLeaseCost
39000 usd
CY2024Q3 us-gaap Sublease Income
SubleaseIncome
50000 usd
CY2023Q3 us-gaap Sublease Income
SubleaseIncome
39000 usd
us-gaap Sublease Income
SubleaseIncome
128000 usd
us-gaap Sublease Income
SubleaseIncome
117000 usd
CY2024Q3 us-gaap Lease Cost
LeaseCost
166000 usd
CY2023Q3 us-gaap Lease Cost
LeaseCost
168000 usd
us-gaap Lease Cost
LeaseCost
454000 usd
us-gaap Lease Cost
LeaseCost
517000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
0 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
5000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
405000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
426000 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
177000 usd
us-gaap Short Term Lease Payments
ShortTermLeasePayments
165000 usd
us-gaap Variable Lease Payment
VariableLeasePayment
39000 usd
us-gaap Variable Lease Payment
VariableLeasePayment
39000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
0 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
419000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
114000 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
149000 usd
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 usd
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
0 usd
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
0 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2023Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
820000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
790000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
820000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
790000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
540000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
543000 usd
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
483000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
456000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1023000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
999000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0 pure
CY2023Q4 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.143 pure
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.096 pure
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.076 pure
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
167000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
536000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
146000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
136000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
161000 usd
CY2024Q3 zvra Finance Lease Liability To Be Paid After Year Four
FinanceLeaseLiabilityToBePaidAfterYearFour
0 usd
CY2024Q3 zvra Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
49000 usd
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1195000 usd
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
-0 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
172000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
0 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1023000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
575000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets
278000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsOther
11000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory
9376000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
35000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Noncurrent Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets
209000 usd
CY2023Q4 zvra Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Approved Product Olpruva
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedApprovedProductOlpruva
68000000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangibles
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles
2000000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
85185000 usd
CY2023Q4 zvra Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accounts Payable And Accrued Expenses
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAccountsPayableAndAccruedExpenses
10881000 usd
CY2023Q4 zvra Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Collaboration Funding
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredCollaborationFunding
1500000 usd
CY2023Q4 zvra Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Operating Lease Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOperatingLeaseLiabilities
175000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
12556000 usd
CY2023Q4 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet
72629000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
3267000 usd
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
14913000 usd
CY2023Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-25900000 usd
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-54763000 usd
CY2024Q3 us-gaap Goodwill
Goodwill
4700000 usd
CY2024Q3 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
2000000 usd
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1500000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
4600000 usd
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P11Y
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P13Y

Files In Submission

Name View Source Status
0001437749-24-034916-index-headers.html Edgar Link pending
0001437749-24-034916-index.html Edgar Link pending
0001437749-24-034916.txt Edgar Link pending
0001437749-24-034916-xbrl.zip Edgar Link pending
ex_716263.htm Edgar Link pending
ex_716264.htm Edgar Link pending
ex_716265.htm Edgar Link pending
ex_716266.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
zvra-20240930.xsd Edgar Link pending
zvra20240930_10q.htm Edgar Link pending
zvra-20240930_def.xml Edgar Link unprocessable
zvra-20240930_lab.xml Edgar Link unprocessable
zvra-20240930_pre.xml Edgar Link unprocessable
zvra20240930_10q_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
zvra-20240930_cal.xml Edgar Link unprocessable